BETHESDA, Md., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc., (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that Matthias Alder, Chief Executive Officer of Gain Therapeutics, will deliver a featured presentation at the Cambridge Healthtech Institute’s 2nd Annual Neurodegeneration Targets Conference: Drug Discovery for Progressive Central Nervous...
First drug candidate identified with Gain’s proprietary computational drug discovery platform SEE-Tx® to enter clinical development phase BETHESDA, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that the Company has received approval from the Bellberry Human Research Ethics Committee (HREC) in...
Treatment with GT-02287 also restored glucocerebrosidase (GCase) enzymatic function, reduced aggregated α-synuclein, neuroinflammation and neuronal death, increased dopamine levels and improved motor function Data presentedat the International Congress of Parkinson's Disease and Movement Disorders® Gain remains on track to begin a Phase 1 clinical study of GT-02287 later this year BETHESDA, Md., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”),...
Parkinson’s News Today
Gain Therapeutics cleared to start GT-02287 Phase 1 trial in Australia
|
Precision Medicine Online
Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia
|
BioWorld
Gain Therapeutics receives Australian HREC approval to begin phase I study of GT-02287 for GBA1-Parkinson’s disease
|
Nasdaq
Gain Therapeutics: Tackling Rare Diseases at the Genetic Level
|
Parkinson’s News Today
Oral therapy GT-02287 shows promise in Parkinson’s mice models
|
The Authority Magazine
The Future Is Now: Matthias Alder Of Gain Therapeutics On How Their Technological Innovations Will Shake Up The Tech Scene
|
July 2023
|
November 11, 2021
|
September 28, 2023
|
September 13, 2023
|
June 7, 2023
|
May 23, 2023
|